DANA COCHRANE - HOEKSTRA: Open Payments
NPI 1295749463 · NORTON SHORES, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,242 in 216 payments from 16 companies in 2025. Trend: 2023 $2,210 · 2024 $2,731 · 2025 $3,242
Food & beverage: $3,234Education: $8
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 46 | $570 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 27 | $497 |
| Alkermes, Inc. | 16 | $323 |
| Neurocrine BioSciences, Inc. | 22 | $314 |
| Supernus Pharmaceuticals, Inc. | 29 | $272 |
| Otsuka America Pharmaceutical, Inc. | 13 | $257 |
| Teva Pharmaceuticals USA, Inc. | 21 | $242 |
| Vanda Pharmaceuticals Inc. | 12 | $202 |
| E.R. Squibb & Sons, L.L.C. | 11 | $173 |
| Corium, LLC | 6 | $109 |
Products named: VRAYLAR, CAPLYTA, INGREZZA, ARISTADA, Qelbree, ABILIFY MAINTENA, AUSTEDO XR, COBENFY.
Industry payments across MI — which companies pay providers there.
